← All Sponsors
SPONSOR

Beam Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Alpha 1-Antitrypsin Deficiency
NCT06389877 Phase 1, Phase 2
Recruiting

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Alpha 1-Antitrypsin Deficiency
United States, Australia, Ireland View Trial →